Skip to content
buyWeak

Vuong Trieu bought $10k of OTLC

CHAIRMAN AND CEO at Oncotelic Therapeutics, Inc.. 500,000 shares at an average of $0.02, traded Aug 23, 2024, filed Aug 27, 2024.

Conviction score
38
Value
$10k
500,000 shares
Holdings after
92,544,217
+1% from before
From 52-week low
0%
low $0.02, close $0.02
From 52-week high
-60%
high $0.05, as of Aug 23, 2024

Score components

  • Role
    CEO
    +25
  • Trade size
    $10k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.5%)
    -5
  • Price context
    0% above the 52-week low; 60% below the 52-week high
    +18
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (2 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m 0.0%, 3m +50.0%, 6m +100.0%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

OTLCOct 12, 2026 · close 0.02
Since filing Aug 27, 2024: 0.0%SPY +42.2% · excess -42.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-24-033939, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 23, 2024POpen-market purchase
Common Stock
+500,000$0.02$10k92,544,217Aug 27, 2024

Related signals

Other insiders at Oncotelic Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
41Moderate
OTLCbuy 2
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$10k
240,000 shares
+0%
41Moderate
OTLCbuy 2
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$11k
255,000 shares
+0%
41Moderate
OTLCbuy 2
Oncotelic Therapeutics, Inc.
Amit B. Shah
CFO
$1,000
20,000 shares
+6%
36Weak
OTLCbuy 2
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$15k
335,759 shares
+0%
24Weak
OTLCbuy
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$994
198,737 shares
+0%
20Weak
OTLCbuy
Oncotelic Therapeutics, Inc.
Vuong Trieu
CHAIRMAN AND CEO
$8,627
298,499 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Vuong Trieu bought $10k of OTLC | InsiderTell